申请人:Sapountzis Ioannis
公开号:US20100240657A1
公开(公告)日:2010-09-23
The present invention encompasses compounds of general formula (1) wherein the groups R
2
to R
4
, L, Q and n are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a pharmaceutical composition with the above-mentioned properties.